1-[3-(2-Methylpyrimidin-4-yl)phenyl]-3-phenylurea

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 1-[3-(2-Methylpyrimidin-4-yl)phenyl]-3-phenylurea
• 化学式: C₁₈H₁₆N₄O
• 分子量: 304.3
• InChiKey: QVFGIZUTWFOJQJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  23
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  66.9
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• Aryl Urea Derivatives for Treating Obesity
  申请人：Bloxham Jason

  公开号：US20080261952A1

  公开（公告）日：2008-10-23

  A method of treating a condition associated with the CB-1 receptor, in particular obesity, by administering an effective amount of an aryl urea CB-1 receptor modulating compound to a subject in need of such treatment.

  通过向需要此类治疗的受试者施用有效量的芳基脲CB-1受体调节化合物来治疗与CB-1受体相关的疾病，尤其是肥胖症的方法。
• Use of Inhibitors of Scavenger Receptor Class Proteins for the Treatment of Infectious Diseases
  申请人：Hannus Michael

  公开号：US20090324580A1

  公开（公告）日：2009-12-31

  The present invention relates to the use of inhibitors of scavenger receptor class proteins, in particular ScarB1 for the production of a medicament for treatment of and/or prophylaxis against infections, involving liver cells and/or hematopoietic cells, in particular malaria.
• USE OF INHIBITORS OF SCAVENGER RECEPTOR CLASS PROTEINS FOR THE TREATMENT OF INFECTIOUS DISEASES
  申请人：HANNUS MICHAEL

  公开号：US20120276121A1

  公开（公告）日：2012-11-01

  The present invention relates to the use of inhibitors of scavenger receptor class proteins, in particular ScarB1 for the production of a medicament for treatment of and/or prophylaxis against infections, involving liver cells and/or hematopoietic cells, in particular malaria.
• US8507546B2
  申请人：——

  公开号：US8507546B2

  公开（公告）日：2013-08-13
• [EN] USE OF INHIBITORS OF SCAVENGER RECEPTOR CLASS PROTEINS FOR THE TREATMENT OF INFECTIOUS DISEASES<br/>[FR] UTILISATION D'INHIBITEURS DE PROTÉINES DE LA CLASSE DES RÉCEPTEURS ÉBOUEURS DANS LE TRAITEMENT DE MALADIES INFECTIEUSES
  申请人：CENIX BIOSCIENCE GMBH

  公开号：WO2007101710A1

  公开（公告）日：2007-09-13

  (EN) The present invention relates to the use of inhibitors of scavenger receptor class proteins, in particular ScarB1 for the production of a medicament for treatment of and/or prophylaxis against infections, involving liver cells and/or hematopoietic cells, in particular malaria.(FR) La présente invention concerne l'utilisation d'inhibiteurs de protéines de la classe des récepteurs éboueurs, en particulier le ScarB1, dans la production d'un médicament destiné au traitement et/ou à la prophylaxie d'infections impliquant des cellules hépatiques et/ou hématopoïétiques, en particulier du paludisme.